{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T15:17:03Z","timestamp":1655911023707},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.ijrobp.2010.10.047","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T14:19:15Z","timestamp":1298557155000},"page":"1278","source":"Crossref","is-referenced-by-count":2,"title":["Cetuximab-Related Radiation Dermatitis in Head-and-Neck Cancer Patients: In Regard to Studer et\u00a0al. (Int J Radiat Oncol Biol Phys In press)"],"prefix":"10.1016","volume":"79","author":[{"given":"Elvio G.","family":"Russi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmauro","family":"Numico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco C.","family":"Merlano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.10.047_bib1","doi-asserted-by":"crossref","unstructured":"Studer G, Brown M, Salgueiro EB, et al. Grade 3\/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT. Int J Radiat Oncol Biol Phys 2010. Available at: http:\/\/www.redjournal.org\/search\/quick [accessed August 28, 2010].","DOI":"10.1016\/j.ijrobp.2010.05.018"},{"key":"10.1016\/j.ijrobp.2010.10.047_bib2","unstructured":"Potthoff K, Hofheinz R, Hassel JC, et al. Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion. Ann Oncol 2010. Available at: http:\/\/www.ncbi.nlm.nih.gov.bvs.cilea.it\/pubmed\/20709812 [accessed September 2, 2010]."},{"key":"10.1016\/j.ijrobp.2010.10.047_bib3","unstructured":"Merlano M, Russi E, Benasso M, et al. Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: A phase II clinical study. Ann Oncol 2010. Available at: http:\/\/annonc.oxfordjournals.org\/content\/early\/2010\/09\/01\/annonc.mdq412.abstract.html?ijkey=eudMvoKseHjz1pz&keytype=ref [accessed September 2, 2010]."},{"key":"10.1016\/j.ijrobp.2010.10.047_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000229752","article-title":"Risk of high-grade skin rash in cancer patients treated with cetuximab\u2014an antibody against epidermal growth factor receptor: Systemic review and meta-analysis","volume":"77","author":"Su","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.ijrobp.2010.10.047_bib5","unstructured":"US Department of Health and Human Services, National Institutes of Health National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC) v. 4. 2009. Available at: http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html [accessed July 10, 2010]."},{"key":"10.1016\/j.ijrobp.2010.10.047_bib6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00520-009-0744-x","article-title":"A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group","volume":"18","author":"Lacouture","year":"2010","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.ijrobp.2010.10.047_bib7","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.jid.5701184","article-title":"The epidermal growth factor receptor system in skin repair and inflammation","volume":"128","author":"Pastore","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ijrobp.2010.10.047_bib8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMc071075","article-title":"Severe cutaneous reaction during radiation therapy with concurrent cetuximab","volume":"357","author":"Budach","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2010.10.047_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00066-008-1829-z","article-title":"Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab","volume":"184","author":"B\u00f6lke","year":"2008","journal-title":"Strahlenther Onkol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610034796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610034796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T20:21:53Z","timestamp":1560025313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610034796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0360301610034796"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.10.047","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}